Slingshot members are tracking this event:
FDA Grants Tentative Approval to Intellipharmaceutics' (IPCI) Seroquel XR for Schizophrenia and Maniac/Mixed Episodes Associated with Bipolar Disorder
Slingshot Insights Explained
Oct 07, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Tentative Approval, Fda, Seroquel Xr, Schizophrenia, Maniac/mixed Episodes, Bipolar Disorder